Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 11, 2024

BUY
$145.54 - $178.83 $69,568 - $85,480
478 Added 7.0%
7,305 $1.27 Million
Q1 2024

Apr 02, 2024

BUY
$165.67 - $199.94 $99,070 - $119,564
598 Added 9.6%
6,827 $1.16 Million
Q4 2023

Jan 02, 2024

SELL
$151.44 - $200.09 $83,292 - $110,049
-550 Reduced 8.11%
6,229 $1.23 Million
Q3 2023

Oct 10, 2023

SELL
$167.14 - $192.77 $123,182 - $142,071
-737 Reduced 9.81%
6,779 $1.18 Million
Q4 2022

Jan 06, 2023

SELL
$131.14 - $157.47 $88,257 - $105,977
-673 Reduced 8.22%
7,516 $1.1 Million
Q2 2021

Jul 07, 2021

SELL
$155.9 - $187.99 $181,623 - $219,008
-1,165 Reduced 12.45%
8,189 $1.53 Million
Q1 2021

May 03, 2021

BUY
$144.0 - $169.39 $32,256 - $37,943
224 Added 2.45%
9,354 $1.47 Million
Q4 2020

Feb 18, 2021

SELL
$157.07 - $174.35 $39,110 - $43,413
-249 Reduced 2.65%
9,130 $1.51 Million
Q3 2020

Nov 03, 2020

BUY
$137.1 - $165.37 $610,095 - $735,896
4,450 Added 90.28%
9,379 $1.55 Million
Q2 2020

Jul 20, 2020

SELL
$111.92 - $142.53 $246,224 - $313,566
-2,200 Reduced 30.86%
4,929 $675,000
Q1 2020

May 15, 2020

BUY
$92.66 - $144.94 $71,533 - $111,893
772 Added 12.14%
7,129 $839,000
Q4 2019

Feb 12, 2020

BUY
$116.25 - $133.25 $45,918 - $52,633
395 Added 6.63%
6,357 $841,000
Q3 2019

Nov 04, 2019

BUY
$112.57 - $128.43 $131,256 - $149,749
1,166 Added 24.31%
5,962 $743,000
Q2 2019

Aug 07, 2019

SELL
$97.98 - $114.28 $274,246 - $319,869
-2,799 Reduced 36.85%
4,796 $544,000
Q1 2019

May 13, 2019

BUY
$81.56 - $100.67 $53,258 - $65,737
653 Added 9.41%
7,595 $765,000
Q4 2018

May 22, 2019

BUY
$79.28 - $95.27 $550,361 - $661,364
6,942 New
6,942 $594,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Symmetry Partners, LLC Portfolio

Follow Symmetry Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Symmetry Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Symmetry Partners, LLC with notifications on news.